Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03317288 · ClinicalTrials.gov registry record · NA
Alternating Pressure Overlay on Weight Bearing Tissue Tolerance in People With Spinal Cord Injury
A NA study, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT03317288 is a NA study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 15 participants.
The verdict
NCT03317288, a NA study, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to test if the newly-developed Dabir alternating pressure (AP) overlay could be beneficial to preventing skin damage during daily activities, such as lying in bed. Specifically, the study is being done to test if the Dabir AP overlay could be used to increase skin tolerance when lying in bed for an extended period of time (40 minutes), including reducing pressure and increasing skin blood flow (amount of blood supply to oxygen and nutrients to skin) as compared to regular operation room (OR) overlay. A total of 20 participants with spinal cord injury will be recruited. Subjects will undergo study procedures including: AP and Control protocols. Skin blood flow and interface pressure will be collected non-invasively (from outside the body) during both protocols. During AP protocols, subject will be asked to lie on side (10 min), on back on AP overlay (40 min), on side (30 min), on back on OR overlay (40 min), and on side (10 min). During Control protocol, subject will be asked to lie on side (10 min), on back on OR overlay (40 min), and on side (10 min). Subject will then proceed to vascular control measures, including: non-invasive skin blood flow and tissue oxygen measurements with mild heating and electrical stimulation. Findings from this study will help us understand the effectiveness of the AP overlay on skin blood flow response during prolonged lying in bed.
Interventions
- DEVICE Dabir Air overlay
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2017-05-12 |
| Est. Completion | 2019-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03317288
The ClinicalTrials.gov registry entry for NCT03317288 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dabir Air overlay is the first listed.
NCT03317288 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03317288 about?
NCT03317288 is a clinical study titled "Alternating Pressure Overlay on Weight Bearing Tissue Tolerance in People With Spinal Cord Injury". The purpose of this study is to test if the newly-developed Dabir alternating pressure (AP) overlay could be beneficial to preventing skin damage during daily activities, such as lying in bed. Specifically, the study is being done to test if the Dabir AP overlay could be used to increase skin tolera...
What is the current status of trial NCT03317288?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2017-05-12. Estimated completion is 2019-03-31.
What interventions are being tested in trial NCT03317288?
The interventions under investigation include: Dabir Air overlay (DEVICE).
Who is sponsoring clinical trial NCT03317288?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.